Opko Health OPK
NASDAQ OPK
$1.71 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Opko Health (OPK) Current Deferred Revenue (2009 - 2024)

Updated

Opko Health (OPK) posted Current Deferred Revenue of $6,000 for Q4 2024, down 14.3% from $7,000 a year earlier.

Analysis

Opko Health (OPK) Current Deferred Revenue (2009 - 2024) Analysis & Trends

  • In prior years, Opko Health's Current Deferred Revenue was $7,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Opko Health 1.27 Bn -393.40 Mn 42.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 6,000.00
Dec 31, 2023 7,000.00
Dec 31, 2017 46.19 Mn
Dec 31, 2016 73.43 Mn
Dec 31, 2014 4.19 Mn
Dec 31, 2013 7.64 Mn
Dec 31, 2012 1.52 Mn
Dec 31, 2011 530,000.00
Dec 31, 2010 321,000.00
Dec 31, 2009 307,000.00
API Access

Opko Health Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OPK&period=max&api_key=YOUR_API_KEY